Skip to main content
. 2019 Feb 26;10(6):1580–1592. doi: 10.7150/jca.27352

Figure 7.

Figure 7

MSI-1 knockdown inhibits Paclitaxel-resistant xenograft tumor growth in vivo. (A)Control group: treated with negative control siRNA(1mg/kg) every 3 days for 5 weeks; (B) Treatment group: treated with MSI-1-siRNA2 (1mg/kg) every 3 days for 5 weeks.